Public Health Foundation Enterprises, Inc. (PHFE)
Policy and Evaluation Research
3311 Florida Street
Oakland
CAUSA
94602
Biographical Sketch: Dr. Valerie Rose has greater than 25 years experience in public health having established her career at the height of the HIV/AIDS epidemic working for the San Francisco Department of Public Health AIDS Office. She served as Director of HIV Prevention from 1989-1998 and concurrently as Director of Policy and Planning from 1993-1998.
Upon completion of her doctorate degree in public health from the University of North Carolina, Gillings Global School of Public Health in 2000, Dr. Rose focused primarily on policy and evaluation research among disenfranchised populations. Population groups that Dr. Rose has specialized expertise include: transgender, gay men and injection drug users. She also has extensive experience bringing diverse communities together to establish priorities using the community planning group process and published a sentinel study (2003) on the policy impact of HIV prevention community planning groups in California. She currently serves as the community co-chair for the California Community Planning Group.
In 2010, Dr. Rose published 3 studies which examine policy interventions designed to expand access to sterile syringes for injection drug users. These studies addressed social justice issues and represented the perspectives of local health departments, policy makers, pharmacists and injection drug users in numerous local health jurisdictions in California. In 2006 she published a study that documented the utility of using a mobile van to provide syringe exchange between midnight and 5 a.m.
Dr. Rose teaches Behavioral Theory and Applied Data Analysis in the MPH Distance Learning Program at San José State University. She also provides consulting services to non-profit and public health organizations and has conducted numerous strategic plans, needs assessments and program evaluations on a variety of health topics. She volunteers her time on behalf of injection drug users.